Cholesterol metabolism is closely related to T cell function, and acyl-CoA: cholesterol acyltransferase 1 (ACAT1) inhibitors improve the anti-tumor function of CD8+ T cells by inhibiting cholesterol esterification in these cells (145). Here, ACAT1 is linked to neoplasm.